# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001193125-18-086721
Filing Date
2018-03-19
Accepted
2018-03-19 08:06:03
Documents
39
Period of Report
2018-03-19
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 8-K | d534167d8k.htm | 8-K | 15289
2 | EX-99.1 | d534167dex991.htm | EX-99.1 | 24627
3 | EX-99.2 | d534167dex992.htm | EX-99.2 | 28840
4 | GRAPHIC | g534167ex99_2s10g1.jpg | GRAPHIC | 171485
5 | GRAPHIC | g534167ex99_2s11g1.jpg | GRAPHIC | 307184
6 | GRAPHIC | g534167ex99_2s12g1.jpg | GRAPHIC | 361877
7 | GRAPHIC | g534167ex99_2s13g1.jpg | GRAPHIC | 254577
8 | GRAPHIC | g534167ex99_2s14g1.jpg | GRAPHIC | 387613
9 | GRAPHIC | g534167ex99_2s15g1.jpg | GRAPHIC | 255630
10 | GRAPHIC | g534167ex99_2s16g1.jpg | GRAPHIC | 289373
11 | GRAPHIC | g534167ex99_2s17g1.jpg | GRAPHIC | 82684
12 | GRAPHIC | g534167ex99_2s18g1.jpg | GRAPHIC | 364814
13 | GRAPHIC | g534167ex99_2s19g1.jpg | GRAPHIC | 264764
14 | GRAPHIC | g534167ex99_2s1g1.jpg | GRAPHIC | 203733
15 | GRAPHIC | g534167ex99_2s20g1.jpg | GRAPHIC | 212071
16 | GRAPHIC | g534167ex99_2s21g1.jpg | GRAPHIC | 303592
17 | GRAPHIC | g534167ex99_2s22g1.jpg | GRAPHIC | 358706
18 | GRAPHIC | g534167ex99_2s23g1.jpg | GRAPHIC | 259230
19 | GRAPHIC | g534167ex99_2s24g1.jpg | GRAPHIC | 379005
20 | GRAPHIC | g534167ex99_2s25g1.jpg | GRAPHIC | 251686
21 | GRAPHIC | g534167ex99_2s26g1.jpg | GRAPHIC | 298237
22 | GRAPHIC | g534167ex99_2s27g1.jpg | GRAPHIC | 83287
23 | GRAPHIC | g534167ex99_2s28g1.jpg | GRAPHIC | 313525
24 | GRAPHIC | g534167ex99_2s29g1.jpg | GRAPHIC | 267321
25 | GRAPHIC | g534167ex99_2s2g1.jpg | GRAPHIC | 358659
26 | GRAPHIC | g534167ex99_2s30g1.jpg | GRAPHIC | 197090
27 | GRAPHIC | g534167ex99_2s31g1.jpg | GRAPHIC | 122514
28 | GRAPHIC | g534167ex99_2s32g1.jpg | GRAPHIC | 502526
29 | GRAPHIC | g534167ex99_2s33g1.jpg | GRAPHIC | 213527
30 | GRAPHIC | g534167ex99_2s34g1.jpg | GRAPHIC | 452065
31 | GRAPHIC | g534167ex99_2s35g1.jpg | GRAPHIC | 273367
32 | GRAPHIC | g534167ex99_2s3g1.jpg | GRAPHIC | 297050
33 | GRAPHIC | g534167ex99_2s4g1.jpg | GRAPHIC | 302194
34 | GRAPHIC | g534167ex99_2s5g1.jpg | GRAPHIC | 326883
35 | GRAPHIC | g534167ex99_2s6g1.jpg | GRAPHIC | 368600
36 | GRAPHIC | g534167ex99_2s7g1.jpg | GRAPHIC | 454429
37 | GRAPHIC | g534167ex99_2s8g1.jpg | GRAPHIC | 296132
38 | GRAPHIC | g534167ex99_2s9g1.jpg | GRAPHIC | 373778
39 | GRAPHIC | g534167g0319011437435.jpg | GRAPHIC | 2795
| Complete submission text file | 0001193125-18-086721.txt |  | 14137955

Mailing Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121 6503662626
HERON THERAPEUTICS, INC. /DE/ (Filer) CIK: 0000818033 (see all company filings)

EIN.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33221 | Film No.: 18697519
SIC: 2834 Pharmaceutical Preparations